Not yet taking people in FrancePhase 1
Tests olaparib with radiotherapy and temozolomide in people with glioblastoma
Tests olaparib, radiotherapy and temozolomide together in adults with glioblastoma.
Plain-language title generated from the registry record
Registry title: Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable high grade gliomas patients
Key facts
- Where
- Amiens Cedex 2, Angers, Bordeaux Cedex, Caen Cedex 5, LE HAVRE, Le Havre Cedex, Lorient, Lyon, Paris, Rouen Cedex, Saint-Herblain Cedex, and Toulouse, FranceSee the 13 sites
- Phase
- Phase 1
Where in France
- CHU De Medecine InterneAmiens Cedex 2, FranceNot yet recruiting
- Institut de Cancerologie de L'OuestAngers, FranceNot yet recruiting
- CHU De BordeauxBordeaux Cedex, FranceNot yet recruiting
- Centre Francois BaclesseCaen Cedex 5, FranceNot yet recruiting
- Centre de Radiothérapie Guillaume le ConquérantLE HAVRE, FranceNot yet recruiting
- Groupe Hospitalier Du HavreLe Havre Cedex, FranceNot yet recruiting
- Groupe Hospitalier Bretagne SudLorient, FranceNot yet recruiting
- Centre Leon BerardLyon, FranceNot yet recruiting
- Hopitaux Universitaires Pitie SalpetriereParis, FranceNot yet recruiting
- Institut CurieParis, FranceNot yet recruiting
- Centre Henri BecquerelRouen Cedex, FranceNot yet recruiting
- Institut De Cancerologie De L OuestSaint-Herblain Cedex, FranceNot yet recruiting
- Oncopole Claudius RegaudToulouse, FranceNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Centre Francois Baclesse
- Trial code
- NCT03212742EU 2024-514144-85-02
- Record updated
- 25 September 2026